Friday, August 12, 2022

USA receives $2.6 million grant to study infection dynamics of an emerging tick-borne virus

Meghan Hermance, Ph.D., assistant professor of microbiology and immunology, is studying the infection dynamics of an emerging tick-borne virus called severe fever with thrombocytopenia syndrome virus or SFTSV.
Tick-borne infections can lead to serious illnesses – and even death – in people and pets. To create effective treatments for these diseases, scientists first must figure out the basic infection biology of the ticks they study. 

Researchers at the University of South Alabama plan to use a $2.6 million grant from the National Institutes of Health to do just that, laying the groundwork for developing a way to stop transmission of an emerging tick-borne virus native to Asia.

Meghan Hermance, Ph.D., an assistant professor of microbiology and immunology at the Whiddon College of Medicine, recently received the five-year award to study the infection dynamics of a tick-borne bunyavirus called severe fever with thrombocytopenia syndrome virus or SFTSV. Thrombocytopenia means low platelet count.

An emerging tick-borne disease caused by the bunyavirus, SFTSV is transmitted by the Haemaphysalis longicornis tick. While the tick is native to East Asia, it recently spread to the United States and beyond, establishing invasive populations.  

The rising incidence of SFTSV cases in Asia, lack of specific treatment strategies, high case fatality rates, and global expansion of the tick vector make the virus a public health concern. Because of its ability to cause hemorrhagic disease and lack of specific treatment strategies, SFTSV is considered a priority infectious disease by the World Health Organization.

“One major focus of this research is to understand how the bunyavirus survives the molting process between tick life stages and the timeline during which the virus disseminates between organs within the tick body,” Hermance said. “In other words, we want to determine where does the virus reside in the tick body before it ends up in the tick salivary glands and ultimately gets transmitted to the next host the tick feeds on.”

A second focus of the research is to define the minimum amount of time an infected tick needs to feed in order to transmit the bunyavirus to a vertebrate host, Hermance said, noting that she and her colleagues also will examine the initial immune response that occurs in the host's skin at the feeding site of the infected tick. 

Collaborators on the research project are Jason Strickland, Ph.D., assistant professor of biology at USA with an adjunct appointment in microbiology and immunology at the Whiddon College of Medicine; and Thuy Phung, Ph.D., associate professor of pathology at the Whiddon College of Medicine and medical director of molecular genetic pathology and dermatopathology. 

Thursday, August 11, 2022

Summer research award winners announced

The Clyde G. Huggins Award for Summer Research winners, from left, are Kahlea Haladwala, Wade Davis, Brandon Barnes, Rachael Motamed and Ryleigh Randall.
The Whiddon College of Medicine announced the top oral and poster presentations from the 49th annual Summer Research Day, held July 22 in the Medical Sciences Building.

Ryleigh Randall, a second-year medical student, won the Clyde G. Huggins Award for Summer Research for her oral presentation “Brain Pericyte Dysfunction in Normal Aging.” Randall’s mentor was Amy Nelson, Ph.D., an assistant professor of physiology and cell biology.

Randall’s project sought to examine the impact of senescence, the arrest of the cell cycle as part of the aging process, on the function of pericytes, cells that surround tiny blood vessels in the brain and help regulate cerebral blood flow.

“As aging is the No. 1 risk factor for developing Alzheimer’s disease and is associated with other forms of damage to the cells of the brain, it is more important than ever to study the impact of normal aging processes on the cells in the brain,” Randall said.

Her project sought to determine if pericyte dysfunction proceeded via the p75 neurotrophin receptor, a protein associated with cellular injury, and if that dysfunction was made worse by the presence of amyloid beta proteins, which are associated with Alzheimer’s disease. The research found that senescent pericytes treated with amyloid beta oligomers were less viable and also expressed higher levels of p75 compared with untreated senescent pericytes.

“Our next steps for the study will include exposing senescent pericytes to a p75 agonist as well as performing cranial window surgeries on aged mice followed by live tissue imaging using a multi-photon microscope in order to measure red blood cell flow through pericyte-covered capillaries in real time,” she said.

The four poster presentation winners, all second-year medical students, were:

  • Rachael Motamed: “Enhancing Wound Healing in Hyper-IGE Syndrome using FPRS as Targets”
  • Kahlea Haladwala: “Correlation of Renal Bladder Ultrasound and Voiding Cystourethrogram in Pediatric Patients Hospitalized for Febrile Urinary Tract Infection”
  • Brandon Barnes: “Blunt Cerebrovascular Injury (BCVI) Management: A Unicorn Diagnosis”
  • Wade Davis: “Breast Cancer Disparities: Racial and Socioeconomic Connection of Molecular Subtypes”

Each winner received a plaque and a $100 prize.

Motamed’s project focused on creating a therapeutic option for patients with a rare, devastating pediatric disease, Hyper IgE syndrome, in which patients suffer from delays in wound healing, which leave them vulnerable to infection. 

“Lung infections, in particular, are life-threatening for patients as infection causes tissue damage that doesn’t resolve, leading to reduced tissue function and susceptibility to further infections,” she said. “Effective therapeutic intervention that enhances wound healing could be more beneficial than any current treatment because this could interrupt the destructive cycle of tissue repair and immune dysfunction.”

Motamed said that new therapeutic options could apply to other diseases that involve wound healing deficiencies, such as acute lung injury and diabetes.

Haladwala worked with pediatrician Maria Roca Garcia, M.D., at USA Health Children’s & Women’s Hospital on finding correlations between different imaging studies used to assess patients with urinary tract infections (UTIs) and fever. “UTIs are the most common bacterial infection affecting young children today, and understanding how to best treat and manage these patients is very important,” she said.

Haladwala’s research investigated correlations between a common ultrasound finding of pelviectasis – when urine gathers in the kidney, making it appear larger than normal – and whether patients with this finding later received a diagnosis of vesicoureteral reflux (VUR), a condition in which urine moves backward in the urinary tract. 

“Our conclusions encouraged further discussion on this topic and the importance of defining pelviectasis as an ultrasound finding so as to best clarify to pediatricians if further imaging is required in those patients,” she said.

Barnes’ research focused on the presence, management and outcomes of blunt cerebrovascular injury in trauma patients at USA Health University Hospital. Blunt cerebrovascular injury is a non-penetrating injury to the blood vessels that supply the brain with blood, mainly the vertebral arteries and internal carotid arteries. The most concerning outcome of these injuries is stroke caused by impaired blood flow to the brain.

“We set out to identify how many of the trauma patients at University Hospital over the past five years suffered this type of injury and experienced a stroke and/or had stroke-like symptoms as a result,” Barnes said. “We also wanted to identify what types of treatments were used for these patients ranging from drug therapy, arterial stents from interventional radiology, and surgical procedures while reviewing the results of any follow-up exams and imaging.”

Davis’ research began as a chart review of 1,200 patients treated for breast cancer at the USA Health Mitchell Cancer Institute between 2017 and 2022. The project classified the patients by body mass index (BMI), race, county of residence and breast cancer subtype to determine what populations were more at risk of developing breast cancer in Mobile and the surrounding area. The project also sought to determine who was more susceptible to triple-negative breast cancer, the most aggressive subtype.

“The results showed that individuals who were African American and had a higher BMI were more at risk of receiving a breast cancer diagnosis, and those same groups with the addition of individuals from lower income counties were most at risk for developing the most aggressive subtype of breast cancer,” he said.

The Clyde G. Huggins Award for Summer Research honors the memory of Clyde G. “Sid” Huggins, who served as the first dean of students at the Whiddon College of Medicine.

The Summer Research Program is an eight-week program that allows medical students to develop an appreciation of how research is needed to improve the prevention, diagnosis and treatment of diseases.

View more photos from Summer Research Day on Flickr

Wednesday, August 10, 2022

Researchers identify novel independent regulator of colon cancer angiogenesis

From left, Chandrani Sarkar, Ph.D., Debanjan Chakroborty, Ph.D., and Sandeep Goswami, Ph.D., are studying a potential therapeutic target for advanced colon cancer at the Mitchell Cancer Institute.

Researchers at the USA Health Mitchell Cancer Institute and the Whiddon College of Medicine have identified neuropeptide Y (NPY) derived from cancer cells as an independent regulator of colon cancer progression. 

Neuropeptides are chemical messenger molecules that co-exist in nerve cells with smaller neurotransmitter molecules, allowing neurons to communicate with one another. NPY is one of the most abundant neuropeptides in the body, widely expressed throughout the central and peripheral nervous systems.

The research, led by Chandrani Sarkar, Ph.D., assistant professor of pathology, recently was published in the British Journal of Cancer. Their findings provide the first evidence that NPY promotes angiogenesis – the formation of new blood vessels from existing vessels – in colon cancer, thereby promoting growth and progression. 

“Angiogenesis is a well-established target for treating several cancers because it is an essential process required for the growth and metastasis of many solid tumors, including colon cancers,” Sarkar said.

Vascular endothelial growth factor-A (VEGF-A) is the most potent angiogenic factor promoting tumor growth and metastasis in colon cancer. Anti-VEGF-A agents, combined with chemotherapy, are used to treat patients with metastatic colon adenocarcinoma. 

Chandrani Sarkar, Ph.D., and Sooraj Kakkat, Ph.D.,
work in the lab at the Mitchell Cancer Institute.
However, the benefits of the presently used anti-angiogenic agents targeting the actions of VEGF-A are limited. Reports indicate that cases of resistance or non-response to anti-VEGF-A therapy have been observed in patients.

Researchers at USA Health have found a potential alternative. Results from their study demonstrate that neuropeptide Y, through its Y2 receptor (Y2R), actively promotes angiogenesis in colon cancer. “Thus, NPY-mediated angiogenic pathway can be an important alternative angiogenic pathway in advanced colon cancer patients,” Sarkar said. 

Using Y2R antagonists alone or adding Y2R antagonists to conventional chemotherapeutic and anti-angiogenic treatment regimens in colon adenocarcinomas that express high levels of NPY is a promising therapeutic strategy, she said. 

Contributing authors from USA Health include Debanjan Chakroborty, Ph.D., a member of the Cancer Biology Program at the MCI and assistant professor of pathology at the Whiddon College of Medicine; and Sandeep Goswami, Ph.D., a postdoctoral researcher at the MCI and the USA Department of Pathology. 

This study was funded by a grant from the National Cancer Institute, National Institutes of Health. The authors are thankful to the Mitchell Cancer Institute and the USA Department of Pathology for the research support they received.   

Read the article in the British Journal of Cancer.

Tuesday, August 9, 2022

Meet a Med Student: Justin Penninger

Justin Penninger

Age: 24

Class of: 2024 

Hometown: Fairhope, Alabama

Undergraduate institution: University of South Alabama 

Degree earned: Bachelor of Science in biology

Interests, hobbies: Plants, food, doodling, woodworking and trying new things

Something unique about me: I’m the youngest of triplets. 

Three of my favorite things: Dogs and cats; my niece, Winnie; and eating 

What I enjoy most about being a student at the Whiddon College of Medicine: What I enjoy most about being a student at South is how supportive my classmates and many of the faculty have been. Everyone is super willing to help one another, and the whole med school community seems to be very supportive of one another. Also, the food and the beaches down here are amazing!



Monday, August 8, 2022

Precision Medicine Traveling Exhibit coming to USA Biomedical Library

The University of South Alabama’s Biomedical Library, in collaboration with the Network of the National Library of Medicine (NNLM), has been selected as a pilot host site for the NNLM All of Us Precision Medicine Traveling Exhibit. The exhibit will be on display in the lobby of the Biomedical Library Aug. 22 to Sept. 23.

Everyone is invited to visit the exhibit to learn about precision medicine and share feedback.

USA Health’s All of Us Research program is partnering with the Biomedical Library to host the exhibit. The Precision Medicine Traveling Exhibit features information about precision medicine, National Library of Medicine health information resources and an introduction to the All of Us Research Program. Learn more about how genetics, lifestyle and environment affect your health and how you can help shape the future of health for yourself, your family, your community and generations to come.

Errol Crook, M.D., professor and Abraham Mitchell Chair of Internal Medicine at the Whiddon College of Medicine and director of USA’s Center for Healthy Communities, will give a presentation about precision medicine on Tuesday, Aug. 23, at 3 p.m. on the second floor of the Biomedical Library. A reception will follow the presentation.

USA Health’s All of Us Research program will host fun and educational activities in the breezeway outside the Biomedical Library Sept. 6 -8 from noon to 2 p.m. Participants can spin the wheel, win a prize and learn how to help shape the future of medicine. To learn more about the All of Us Research Program, visit joinallofus.org or call 251-471-7708 to schedule an appointment to enroll.